D Anders Hove

Affiliations

  • at Onkure Therapeutics Inc. (OKUR), 2025-05-19
  • Director at Arca Biopharma Inc. (ABIO), 2024-01-31
  • Large Shareholder at Inspire Medical Systems Inc. (INSP), 2018-05-10
  • Director at Anacor Pharmaceuticals Inc. (ANAC), 2016-06-24
  • Director at Edge Therapeutics Inc. (EDGE), 2015-10-08
  • Large Shareholder at Avalanche Biotechnologies Inc. (AAVL), 2014-08-07
  • Large Shareholder at Ironwood Pharmaceuticals Inc (IRWD), 2013-03-20
  • Large Shareholder, Director at World Heart Corp (WHRT), 2012-08-06
  • Large Shareholder at Chelsea Therapeutics International Ltd. (CHTP), 2011-02-04
  • Director at Trubion Pharmaceuticals Inc (TRBN), 2010-10-28
  • Large Shareholder, Director at Alimera Sciences Inc (ALIM), 2010-04-28
  • Large Shareholder at Neurocrine Biosciences Inc (NBIX), 2010-01-05
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
EDGE $11.00 450,000 $4,950,000.00 2,021,917 2015-10-06 Filing
ANAC $5.00 600,000 $3,000,000.00 2,625,535 2010-11-30 Filing
ALIM $11.00 306,071 $3,366,781.00 3,949,070 2010-04-27 Filing
WHRT $5.15 388,350 $2,000,002.50 4,055,016 2010-01-21 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ANAC $98.93 72,385 $7,161,048.05 0 2016-05-16 Filing
ANAC $99.41 199,865 $19,868,579.65 72,385 2016-05-16 Filing
ANAC $100.60 81,631 $8,212,078.60 272,250 2016-05-16 Filing
ANAC $71.40 400 $28,560.00 96,234 2016-04-08 Filing
ANAC $70.05 3,868 $270,953.40 96,634 2016-04-08 Filing